On December 19, 2006, the United States Food and Drug Administration issued an “Alert” regarding the safety of Rituxan use in patients suffering from rheumatologic illnesses.This alert was issued because there were two reported cases of fatal Progressive Multifocal Leukoencepholopathy, more con...
-
Rituxan and PML risk
Maria
Sunday, September 23, 2007 at 07:45 AMI am a rheumatoid arthritis patient considering Rituxan treatment and although the statistics support that PML is rare in the RA population, it gives one pause before beginning treatment.
- Font size
- Email This
- Bookmark
- Thank you for your input
- Save
- RSS
- Report Abuse
What the community is saying...
Do We Look Sick to You?
Posted 10/28 Comments (5)
The winter after I was diagnosed with rheumatoid...
